Get the Stockscreener App
112.02
1.25%
1.38
After Hours:
110.90
-1.12
-1.00%
Zimmer Biomet Holdings Inc stock is traded at $112.02, with a volume of 1.21M.
It is up +1.25% in the last 24 hours and up +9.45% over the past month.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
See More
Previous Close:
$110.64
Open:
$110.84
24h Volume:
1.21M
Relative Volume:
0.81
Market Cap:
$22.28B
Revenue:
$7.60B
Net Income/Loss:
$1.08B
P/E Ratio:
46.48
EPS:
2.41
Net Cash Flow:
$1.26B
1W Performance:
+2.52%
1M Performance:
+9.45%
6M Performance:
-3.77%
1Y Performance:
-1.60%
1-Day Range:
$110.51
$112.66
1-Week Range:
$108.28
$112.66
52-Week Range:
$101.47
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Name
Zimmer Biomet Holdings Inc
Sector
Industry
Phone
(574) 267-6131
Address
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
112.02 | 22.28B | 7.60B | 1.08B | 1.26B | 2.41 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-10-24 | Initiated | Wolfe Research | Peer Perform |
| Jul-01-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| May-21-24 | Upgrade | Argus | Hold → Buy |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Aug-28-23 | Upgrade | BTIG Research | Neutral → Buy |
| May-03-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-11-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-31-23 | Upgrade | Jefferies | Underperform → Hold |
| Mar-29-23 | Initiated | UBS | Sell |
| Mar-10-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-05-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-18-22 | Initiated | Barclays | Underweight |
| Oct-12-22 | Initiated | Jefferies | Underperform |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Apr-01-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Underperform |
| Mar-02-22 | Downgrade | Loop Capital | Buy → Hold |
| Feb-08-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-08-22 | Reiterated | Citigroup | Buy |
| Feb-08-22 | Reiterated | Deutsche Bank | Hold |
| Feb-08-22 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-08-22 | Reiterated | JP Morgan | Neutral |
| Feb-08-22 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-08-22 | Reiterated | Stifel | Buy |
| Feb-08-22 | Reiterated | Truist | Buy |
| Feb-08-22 | Reiterated | UBS | Neutral |
| Feb-08-22 | Reiterated | Wells Fargo | Underweight |
| Feb-02-22 | Downgrade | UBS | Buy → Neutral |
| Jan-19-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-10-22 | Downgrade | Mizuho | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-09-21 | Downgrade | Needham | Strong Buy → Buy |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Nov-23-21 | Downgrade | Argus | Buy → Hold |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-09-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-18-20 | Reiterated | Needham | Strong Buy |
| Oct-20-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Aug-05-20 | Reiterated | Needham | Strong Buy |
| Apr-28-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-07-20 | Reiterated | Needham | Strong Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jan-07-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-19 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-07-19 | Upgrade | BTIG Research | Neutral → Buy |
| Sep-18-19 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-12-19 | Upgrade | Argus | Hold → Buy |
| Jul-30-19 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-29-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jun-11-19 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Apr-24-19 | Upgrade | Needham | Buy → Strong Buy |
View All
Zimmer Biomet Holdings Inc Stock (ZBH) Latest News
Zacks Research Cuts Earnings Estimates for Zimmer Biomet - MarketBeat
Zimmer Biomet receives FDA premarket approval for Oxford cementless partial TKR implant - Healio
FDA approves Zimmer Biomet's cementless knee implant By Investing.com - Investing.com South Africa
Charles Schwab Investment Management Inc. Lowers Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer wins FDA approval for cementless partial knee implant - Yahoo Finance
Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S. - The Malaysian Reserve
FDA approves Zimmer Biomet's cementless knee implant - Investing.com India
ZBHZimmer Biomet Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Zimmer Biomet's Oxford® Cementless Knee Gets FDA Breakthrough Approval, First in US | ZBH Stock News - StockTitan
Q4 EPS Estimates for Zimmer Biomet Lifted by Zacks Research - MarketBeat
Studio Investment Management LLC Boosts Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Landscape Capital Management L.L.C. Purchases New Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Moran Wealth Management LLC Has $309,000 Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat
Is Wall Street Bullish or Bearish on Zimmer Biomet Stock? - MSN
Brokers Offer Predictions for Zimmer Biomet FY2024 Earnings - MarketBeat
Investors in Zimmer Biomet Holdings (NYSE:ZBH) have unfortunately lost 21% over the last five years - Simply Wall St
PNC Financial Services Group Inc. Has $18.55 Million Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Natixis Advisors LLC Raises Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Mutual of America Capital Management LLC Trims Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Announces Third Quarter 2024 Financial Results - GuruFocus.com
Zimmer Biomet to Present at Jefferies London Healthcare Conferen - GuruFocus.com
Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Arnold Schwarzenegger Joins Zimmer Biomet Holdings, Inc. - https://ryortho.com/
Is Wall Street Bullish Or Bearish On Zimmer Biomet Stock? - Barchart
Thompson Siegel & Walmsley LLC Takes $41.59 Million Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet to Present at Citi’s 2024 Global Healthcare Conference - The Malaysian Reserve
Zimmer Biomet to Present at Citi Global Healthcare Conference in December | ZBH Stock News - StockTitan
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Primecap Management Co. CA - MarketBeat
Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference – Company Announcement - Financial Times
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Quest Partners LLC - MarketBeat
Zimmer Biomet Holdings (ZBH) Completes €700 Million Notes Issuan - GuruFocus.com
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System - MSN
Zimmer Biomet received warning letter from FDA on May 31SEC Filing - Reuters.com
Banque Cantonale Vaudoise Raises Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Acquires New Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
KBC Group NV Increases Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet's Leading Knee Revision System Gains CE Mark for European Expansion | ZBH Stock News - StockTitan
Corbyn Investment Management Inc. MD Acquires 13,963 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Equity Investment Corp Invests $70.10 Million in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Thrivent Financial for Lutherans Cuts Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
ING Groep NV Sells 90,246 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
UBS: Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Is A Bottom-Ranked Quant Stock - Yahoo Finance
Sumitomo Mitsui Trust Group Inc. Lowers Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives $123.22 Consensus Target Price from Analysts - MarketBeat
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Sivik Global Healthcare LLC Buys New Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet's SWOT analysis: stock outlook amid ERP challenges, growth plans - Investing.com Australia
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Position Lessened by Assetmark Inc. - MarketBeat
Zimmer Biomet Holdings Inc Stock (ZBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):